Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

NCT04923828 · tracked via the Priya Life Science China tracker

Sponsor

Children's Hospital of Fudan University

Phase

Observational

Started

2023-12-31

Last updated

2026-02-17

Condition(s) studied

Severe Infection

Study summary

To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.

Eligibility

Sex

ALL

Min age

1 Month

Max age

16 Years

Healthy volunteers

Inclusion Criteria: * PICU patients with severe infection Exclusion Criteria: * Non-infected patient

Primary outcome measure(s)

Pathogenic spectrum of PICU severe infection — 2016-2025
the 10 years of pathogenic spectrum of PICU severe infection

Trial sites (1)

Facility	City	Region	Status
Children's Hospital of Fudan University	Shanghai	Shanghai Municipality	Recruiting

More Children's Hospital of Fudan University trials in China

PK/PD of Caspofungin in Children Severe Infection Recruiting

Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery Enrolling by invitation

Dupilumab Therapy for EGIDs Recruiting

Child-Parent Familial Hypercholesterolemia Screening Recruiting

Blood Purification in Septic Children Starting soon

Other trials for the same condition

Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04923828 on ClinicalTrials.gov ↗ ← All trials in China